Gross profit increased 54.0%
Gross profit changed +54.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross profit changed +54.0% from the comparable as-filed period.
Capital expenditure changed +634.9% from the comparable as-filed period.
Working capital / assets changed +670 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow / net income changed +108.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / revenue changed -1011 basis points from the comparable as-filed period.
Debt / assets changed -623 basis points from the comparable as-filed period.
Cash / debt changed +46005 basis points from the comparable as-filed period.
Stock-based compensation changed +36.5% from the comparable as-filed period.
Cash & equivalents changed +1195.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Operating cash-flow margin changed +273 basis points from the comparable as-filed period.
Shares outstanding changed +9.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net debt changed -803.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Current ratio changed +9.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -80 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -12 basis points from the comparable as-filed period.
Gross debt changed +4.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Reported total debt changed +4.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -26 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current long-term debt changed -0.4% from the comparable as-filed period.
Capital expenditure changed +711.7% from the comparable as-filed period.
Gross profit changed +55.7% from the comparable as-filed period.
Operating cash flow / net income changed +54.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +49.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +348 basis points from the comparable as-filed period.
Working capital / assets changed -899 basis points from the comparable as-filed period.
Debt / revenue changed -1264 basis points from the comparable as-filed period.
Debt / assets changed -559 basis points from the comparable as-filed period.
Cash / debt changed +3135 basis points from the comparable as-filed period.
Gross margin changed -53 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed +34 basis points from the comparable as-filed period.
Stock-based compensation changed +27.0% from the comparable as-filed period.
Current ratio changed -14.7% from the comparable as-filed period.
Free-cash-flow margin changed -101 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross debt changed -7.6% from the comparable as-filed period.
Reported total debt changed -7.6% from the comparable as-filed period.
Shares outstanding changed -0.0% from the comparable as-filed period.
SBC / revenue changed -11 basis points from the comparable as-filed period.
Working capital changed -3.8% from the comparable as-filed period.
R&D / revenue changed -19 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current long-term debt changed -0.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.